Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
New England Journal of Medicine · 23.10.2025 · 393 (16) · 1599-1611
DOI: 10.1056/nejmoa2508170 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 23.10.2025. Verfasst von Vallerie V McLaughlin und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan Medical School, Ann Arbor. Hauptthemen laut MEDLINE: Activins, Hypertension, Pulmonary, Pulmonary Arterial Hypertension, Recombinant Fusion Proteins. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Michigan Medical School, Ann Arbor.
- Hannover Medical School and the German Center for Lung Research, Hannover, Germany.
- University of Colorado, Anschutz Medical Campus, Aurora.
- Department of Internal Medicine, Justus-Liebig University Giessen, Universities of Giessen and Marburg Lung Center, Member of the German Center for Lung Research, Giessen, Germany.
- National Heart and Lung Institute, Imperial College London, London.
- George Washington University School of Medicine and Health Sciences, Washington, DC.
ORCID-Profile: Marius M Hoeper, H Ardeschir Ghofrani, Mardi Gomberg-Maitland, Rogerio Souza, Marc Humbert
Förderung
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Zitieren
APA
McLaughlin, V. V., Hoeper, M. M., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., Preston, I. R., Souza, R., Waxman, A. B., Kopeć, G., Meyer, G., Olsson, K. M., Fu, W., Shi, Y., Miller, B., Kim, S. S., Mackenzie, H. S., Brambatti, M., Patel, M. J., …, & HYPERION Trial Investigators (2025). Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis. New England Journal of Medicine, 393(16), 1599-1611. https://doi.org/10.1056/nejmoa2508170
Vancouver
McLaughlin VV, Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, et al. Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis. New England Journal of Medicine. 2025;393(16):1599-1611. doi:10.1056/nejmoa2508170
BibTeX
@article{McLaughlin2025,
author = {McLaughlin, Vallerie V and Hoeper, Marius M and Badesch, David B and Ghofrani, H Ardeschir and Gibbs, J Simon R and Gomberg-Maitland, Mardi and Preston, Ioana R and Souza, Rogerio and Waxman, Aaron B and Kopeć, Grzegorz and Meyer, Gisela and Olsson, Karen M and Fu, Wei and Shi, Yaru and Miller, Barry and Kim, Samuel S and Mackenzie, Harald S and Brambatti, Michela and Patel, Mahesh J and Koglin, Joerg and Cornell, Alexandra G and Humbert, Marc and HYPERION Trial Investigators, HYPERION Trial Investigators},
title = {Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {16},
pages = {1599--1611},
doi = {10.1056/nejmoa2508170}
}
EUVIMED